The acquisition gives GSK access to camlipixant, which is in late-stage development for the first-line treatment of adult patients with ref...

ET Now, quoting agencies, said GSK PLc is likely to start the discussion of its stake in the next few days.

GSK brands like Horlicks, Boost, Maltova and Viva have come to HUL’s portfolio as part of the merger.

Officials aware of the developments say Morgan Stanley is readying the share sale process.

The company is hoping to cash out what will be a near 6 per cent stake in HUL.

Unilever edged past Nestle, the world’s largest food and drinks company, in a closely fought battle.

GSK CH’s sales are down from Rs 4,683 crore in FY14 to Rs 3,986 crore in FY17.

GSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.

GlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.

GSK said that it was looking to buy a 24% stake in the pharmaceuticals subsidiary for about $1billion or Rs 6,400 crore.

"As India develops, there will be a growing focus on more medicines and vaccines which are required," Redfern said.

It may be the season of open offers by MNCs. GlaxoSmithKline Consumer started it earlier this year, followed by Unilever and, the latest, M...

The cross-functional collaboration deal, to swap select brands and independently market, sell and distribute them, is one of the four lever...

"We have been obviously launching the offer to acquire up to 75% and what we think is hopefully an attractive premium for the current share...

The Indian arms of most global pharma giants have so far remained under-sized, rather off their parent’s radar for sometime now. But are th...

GlaxoSmithKline (GSK) Plc and Tata Consultancy Services (TCS) on Tuesday announced an agreement to establish a global drug development supp...